article thumbnail

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT

At the urging of the Alliance for Pharmacy Compounding, the trade association I lead, the Food and Drug Administration in April 2020 issued temporary guidance allowing traditional compounding pharmacies, within tight regulatory guardrails, to prepare 13 Covid drugs from pure ingredients to meet hospitals’ urgent need.

article thumbnail

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of targeted cancer drugs; Novo sues two more compounders

STAT

Food and Drug Administration approval for advanced ovarian cancer in 2022. Novo Nordisk filed lawsuits against two compounding pharmacies for selling adulterated and misbranded compounded drugs claiming to contain semaglutide, the active ingredient in Wegovy and Ozempic (see here and here ).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls

STAT

One of the largest compound pharmacy operations in the U.S. For example, there were 100 instances between November 2022 and March 2023 in which the company found what the FDA called a “significant number” of bacteria, yeast, mold, and other spore-forming organisms. facility run by Central Admixture Pharmacy Services.

article thumbnail

STAT+: Pharmalittle: We’re reading about compounders suing the FDA, Biogen turning to telehealth, and more

STAT

… A trade group representing large compounding pharmacies has sued the U.S. from 1967 until 2022. So join us as we hoist the ever-present cup of stimulation — our choice today is coconut rum — and attack the fast-growing to-do list. Have a grand day, everyone, and do stay in touch.

article thumbnail

STAT+: Pharmalittle: We’re reading about Pfizer struggles with Starboard, Lilly going after compounders, and more

STAT

in 2022, breaking a decade-long trend of nearly continuous annual increases in the share of graduates headed for the private sector. in 2022 to 22.1%. in 2022 and 66% in 2021. in 2022 and 66% in 2021. That’s a sizable dip from 66.5% Continue to STAT+ to read the full story…

article thumbnail

Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss medications

Express Pharma

It results in less weight loss on average than Novo’s newer in-demand Wegovy, which launched in 2020 and was approved in 2022 for adolescents aged 12 and older. Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication kits at $79 per month. regulations.

article thumbnail

Rapid microbiology testing market growth expected 2022 to 2027

European Pharmaceutical Review

A report has predicted the rapid microbiology testing market size is estimated to grow at a compound annual growth rate (CAGR) of 9.31 percent between 2022 and 2027. The research includes historic market data from 2017 to 2021, using 2022 as the base year. According to the data, the market is forecasted to increase by $2,487.91